Pulmonary absorption enhancement of salmon Calcitonin

Journal of Drug Targeting

Volumn 12, Issue 3, 2004, Pages 135-144

  Kumar, T Mahesh ^a   Misra, A ^a  

^a M S UNIVERSITY OF BARODA   (India)

Author keywords

Calcitonin; Percent blood calcium reduction; Pharmacodynamics; Relative pulmonary bioactivity

Indexed keywords

ACETIC ACID; AMASTATIN; BACITRACIN; BESTATIN; BETA CYCLODEXTRIN DERIVATIVE; BUFFER; CHYMOSTATIN; PROTEINASE INHIBITOR; SALCATONIN; TAUROGLYCOCHOLIC ACID;

ANIMAL EXPERIMENT; ANIMAL MODEL; AREA UNDER THE CURVE; ARTICLE; CALCIUM DEPLETION; CONCENTRATION RESPONSE; CONTROLLED STUDY; DOSE RESPONSE; DRUG ABSORPTION; DRUG ACTIVITY; DRUG DISTRIBUTION; DRUG FORMULATION; DRUG PENETRATION; DRUG POTENTIATION; DRUG SOLUBILITY; DRUG SOLUTION; HYPOCALCEMIA; MALE; NONHUMAN; PH; PRIORITY JOURNAL; RAT; RESPIRATORY SYSTEM; STATISTICAL SIGNIFICANCE;

ADJUVANTS, PHARMACEUTIC; ADMINISTRATION, CUTANEOUS; ANIMALS; BIOLOGICAL AVAILABILITY; CALCITONIN; CALCIUM; DOSE-RESPONSE RELATIONSHIP, DRUG; HYDROGEN-ION CONCENTRATION; INJECTIONS, SUBCUTANEOUS; INSTILLATION, DRUG; LUNG; MALE; PERMEABILITY; RATS; TECHNOLOGY, PHARMACEUTICAL; TIME FACTORS;

EID: 3042722164     PISSN: 1061186X     EISSN: None     Source Type: Journal    
DOI: 10.1080/1061186042000223644     Document Type: Article

References (27)

1. Ahsan, F., Arnold, J.J., Meezan, E. and Pillion, D.J. (2001) "Mutual inhibition of the insulin absorption enhancing properties of dodecyl maltoside and dimethyl cyclodextrin following nasal administration", Pharm. Res. 18, 608-614.
2. Alberts, B., Bray, D., Lewis, J., Raff, M., Roberts, K. and Watson, J.D. (1989) "Cell adhesion, cell junctions and the Extracellular matrix", Molecular Biology of the Cell (Gerland, New York), pp. 791-836.
3. Audus and Thomas, J.R. (1993) Biological barriers to protein drug delivery Pharmaceutical Biotechnology, (Plenum Press, New York and London) Vol. 4, pp. 23-50.
4. Davis, S.S. (1999) "Delivery of peptide and non-peptide drugs through the respiratory tract", Pharm. Sci. Technol. Today 12, 450-459.
5. Deftos, L.J., Nolan, J.J., Seely, B.L., Clopton, P.L., Cote, G.J., Whitham, C.L., Florex, L.J., Christensen, T.A. and Hill, M.R. (1997) "Intrapulmonary drug delivery of Salmon Calcitonin", Calcif. Tissue Int. 61, 345-347.
6. Devore, J.L. and Farnum, N.R. (1999) Applied Statistics for Engineers and Scientists (Duxbury Press/International Thomson Publishing Inc.), pp 394-398.
7. Enna, S.J. and Schanker, L.S. (1972) "Absorption of saccharides and urea from the rat lung", Am. J. Physiol. 222, 409-414.
8. Gordon, G.S., Moses, A.C., Silver, R.D., Flier, J.S. and Carey, M.C. (1985) "Nasal absorption of insulin enhancement by bile salts", Proc. Natl Acad. Sci. USA 82, 7419-7423.
9. Hochman, J. and Artursson, P. (1994) "Mechanism of absorption enhancement and tight junction regulation", J. Control. Release 29, 253-267.
10. Khan, M.J., Lakshminarayanaiah, N., Trotman, B.W., Chun, P., Kaplan, S.A. and Margulies, C. (1982) "Calcium binding and bile salt structure", Hepatology 2, 732.
11. Kobayashi, S., Kondo, S. and Juni, K. (1994) "Study on pulmonary delivery of salmon calcitonin in rats: effects of protease inhibitors and absorption enhancers", Pharm. Res. 11, 1239-1243.
12. Kobayashi, S., Kondo, S. and Juni, K. (1996) "Pulmonary delivery of salmon calcitonin dry powders containing absorption enhancers in rats", Pharm. Res. 13, 80-83.
13. Komada, F., Iwakawa, S., Yamamoto, N., Sakakibara, H. and Okumura, K. (1994) "Intratracheal delivery of peptide and protein agents: absorption from solution and dry powder by rat lung", J. Pharm. Sci. 83, 863-867.
14. Lee, V.H.L. (1990) "Protease inhibitors and penetration enhancers as approaches to modify peptide absorption", J. Control. Rel. 13, 213-223.
15. Lee, K.C., Lee, Y.J., Song, H.M., Chun, C.J. and Oeluca, PP. (1992) "Degradation of synthetic salmon calcitonin in aqueous solution", Pharm. Res. 9, 1521-1523.
16. Lee, K.C., Soltis, E.E., Newman, P.S., Burton, K.W., Mehta, R.C. and DeLuca, P.P. (1991) "In vivo assessment of salmon calcitonin sustained release from biodegradable microspheres", J. Control. Release 17, 199-206.
17. Maini, M., Bozzi, M., Brignoli, et al. (1995) "Calcitonin nasal spray in osteoporosis: short and long-term effects of various treatment regimens", Minerva Med. 86, 121-127.
18. Martin, Mc.C., Hutchinson, L.E.F., Hyde, R. and Peters, G.E. (1987) "Analysis of structural requirements for the absorption of drugs and macromolecules from the nasal cavity", J. Pharm. Sci. 70, 535-540.
19. Marttin, E., Verhoef, J.C. and Merkus, F.W.H.M. (1997) "Efficacy, safety and mechanism of cyclodextrins as absorption enhancers in nasal delivery of peptide and protein drugs", J. Drug Target. 6, 17-36.
20. Munoz, B.Y., Domingo, A.R. and Minguella, J.F. (2000) "Calcitonin: Osteoporosis treatment and prevention", Drugs Today 36(Suppl. D), 13-25.
21. Patton, J.S., Trinchero, P. and Platz, R.M. (1994) "Bioavailability of pulmonary delivered peptide and protein: interferon alpha, calcitonin and parathyroid hormones", J. Control. Rel. 28, 79-85.
22. Patton, J.S., Bukar, J. and Nagarajan, S. (1999) "Inhaled insulin", Adv. Drug Delivery Rev. 35, 235-247.
23. Physician Desk Reference, 51st Edition (1997). Medical Economics, Montvalc, NJ, pp. 2403-2405.
24. Rico, H., Revilla, M. and Hernandez, M. (1995) "Total and regional bone mineral content and fracture rate in postmenopausal osteoporosis treated with salmon calcitonin: a prospective study", Cacif. Tissue Int. 56, 181-185.
25. Seeman, E., Tsalamandris, C. and Bass, S. (1995) "Present and future of osteoporosis therapy", Bone 87, 203-209.
26. Silverman, S., Chesnut, C. and Andriano, K. (1998) "Salmon Calcitonin nasal spray reduces risk of vertebral fractures(s) in established osteoporosis and has continuous efficacy with prolonged treatment: Accrued 5-year worldwide data of the PROOF study", Bone 23(Suppl. 5), S 174.
27. Yamomoto, A., Hayakawa, E. and Lee, H.L. (1990) "Insulin and pro-insulin proteolysis in mucosal homogenate of the albino rabbit; Implications in peptide delivery from non-oral routes", Life Sci. 47, 2465-2474.